Skip to content
CIRI-IT
  • HOME_
  • Organization
    • The Origins
    • The Scientific Committee
    • The Center’s Objectives
    • Future Perspectives
  • Research
    • Study on RSV epidemiology and impact: RESPIRA 50
    • RSV ComNet Project
    • EPSS Studies
    • ID.DRIVE
  • Publications
  • News_
    • Nirsevimab: a new opportunity for RSV prevention in Newborns
    • Sexually transmitted diseases
    • Prevention and control of Influenza – 2024–2025 Season
  • Contacts
    • Newsletter
  • NVPP 2023–2025
  • Italiano
  • English
  • Toggle website search
Search this website
Menu Close
  • HOME_
  • Organization
    • The Origins
    • The Scientific Committee
    • The Center’s Objectives
    • Future Perspectives
  • Research
    • Study on RSV epidemiology and impact: RESPIRA 50
    • RSV ComNet Project
    • EPSS Studies
    • ID.DRIVE
  • Publications
  • News_
    • Nirsevimab: a new opportunity for RSV prevention in Newborns
    • Sexually transmitted diseases
    • Prevention and control of Influenza – 2024–2025 Season
  • Contacts
    • Newsletter
  • NVPP 2023–2025
  • Italiano
  • English
  • Toggle website search
Read more about the article Second-generation anti-influenza drugs

Second-generation anti-influenza drugs

Continue ReadingSecond-generation anti-influenza drugs
Read more about the article First-generation anti-influenza drugs

First-generation anti-influenza drugs

Continue ReadingFirst-generation anti-influenza drugs
Read more about the article Symptomatic Drugs

Symptomatic Drugs

Continue ReadingSymptomatic Drugs
Read more about the article Influenza

Influenza

What Is Influenza? Influenza is a seasonal infectious disease caused by influenza viruses. There are three distinct types of influenza…

Continue ReadingInfluenza
← Newer Posts

Search

CM_EN

  • HOME_
  • Organization
    • The Origins
    • The Scientific Committee
    • The Center’s Objectives
    • Future Perspectives
  • Research
    • Study on RSV epidemiology and impact: RESPIRA 50
    • RSV ComNet Project
    • EPSS Studies
    • ID.DRIVE
  • Publications
  • News_
    • Nirsevimab: a new opportunity for RSV prevention in Newborns
    • Sexually transmitted diseases
    • Prevention and control of Influenza – 2024–2025 Season
  • Contacts
    • Newsletter
  • NVPP 2023–2025
  • Italiano
  • English

Restricted Area

  • Accesso
  • DISSAL
  • UNIGE
© Copyright 2023 - CIRI-IT InterUniversity Research Center on Influenza

SPECIALE COVID-19

Lorem ipsum dolor sit amet, consectetur adipiscing elit. In pulvinar erat ut venenatis maximus. Duis varius fermentum imperdiet. Morbi ipsum odio, ultricies non diam et, consectetur auctor lacus. Nunc a mi tellus. Nullam sit amet urna imperdiet, malesuada enim et, rutrum libero. Donec vel orci quis felis dapibus lobortis et at diam. Suspendisse at vehicula risus, maximus pretium dolor. Duis congue dolor nec ante dapibus, et venenatis libero finibus. Donec in mattis est. Morbi euismod, metus at lobortis rhoncus, lacus arcu malesuada lectus, sed pharetra magna diam ut purus. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Integer quis lorem vulputate, elementum lacus non, porta ipsum.